Sign In
Buy ARGX
$844.50
+13.71 (+1.65%)
At Close: Aug 04, 2026
Should You Buy argenx SE (ARGX) Ahead of Earnings?
05:25pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
argenx SE (ARGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Materialise (MTLS) to Report Q4 Earnings: What's in Store?
01:51pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
Materialise's (MTLS) fourth-quarter 2021 earnings are likely to have benefited from solid operational performance in all three segments.
argenx to Present at the 42nd Annual Cowen Health Care Conference
06:00am, Monday, 28'th Feb 2022 GlobeNewswire Inc.
February 28, 2022Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today an
argenx SE (ARGX) is Artisan Partners’ Top Contributor
03:57am, Monday, 28'th Feb 2022 Insider Monkey
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded here.
argenx to Present at the 42nd Annual Cowen Health Care Conference
01:00am, Monday, 28'th Feb 2022
February 28, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today a
Splunk (SPLK) to Report Q4 Earnings: What's in the Cards?
02:06pm, Friday, 25'th Feb 2022 Zacks Investment Research
Splunk's (SPLK) fourth-quarter fiscal 2022 performance is likely to have benefited from solid demand for cloud-based solutions and customer additions.
SEMrush (SEMR) to Report Q4 Earnings: What's in the Cards?
02:02pm, Friday, 25'th Feb 2022 Zacks Investment Research
SEMrush's (SEMR) fourth-quarter 2021 performance is likely to have benefited from growth in user licenses per customer along with strength in product add-ons.
Steven Cohen's Interest in IDEAYA Increases
10:23am, Friday, 25'th Feb 2022
Steven Cohen (Trades, Portfolio), leader of Point72 Asset Management, disclosed earlier this week he increased his stake in IDEAYA Biosciences Inc. ( IDYA , Financial) by 52.12%.
argenx to Report Full Year 2021 Financial Results and Fourth Quarter Business Update on March 3, 2022
06:00am, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
February 24, 2022Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today an
argenx to Report Full Year 2021 Financial Results and Fourth Quarter Business Update on March 3, 2022
01:00am, Thursday, 24'th Feb 2022
February 24, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today a
argenx to Present at the 11th Annual SVB Leerink Global Healthcare Conference
01:00am, Thursday, 10'th Feb 2022
February 10, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today a
12 biotech stocks to consider buying now as prospects for the sector brighten this year
02:01pm, Monday, 07'th Feb 2022 MarketWatch
Biotechnology is so beaten down, relative valuation metrics suggest some stocks could more than double.
12 biotech stocks to consider buying now as prospects for the sector brighten this year
04:53pm, Sunday, 06'th Feb 2022
Biotechnology is so beaten down, relative valuation metrics suggest some stocks could more than double
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
01:28pm, Thursday, 20'th Jan 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In Endometrial Cancer
Eisai Co.
argenx to Present at 40th Annual J.P. Morgan Healthcare Conference
06:00am, Monday, 03'rd Jan 2022 GlobeNewswire Inc.
January 3, 2022Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today anno
